190 related articles for article (PubMed ID: 9671117)
1. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
Masumiya H; Shijuku T; Tanaka H; Shigenobu K
Eur J Pharmacol; 1998 May; 349(2-3):351-7. PubMed ID: 9671117
[TBL] [Abstract][Full Text] [Related]
2. Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
Masumiya H; Tanaka H; Shigenobu K
Eur J Pharmacol; 1997 Sep; 335(1):15-21. PubMed ID: 9371541
[TBL] [Abstract][Full Text] [Related]
3. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
[TBL] [Abstract][Full Text] [Related]
4. Effects of S(+)-efonidipine on the rabbit sinus node action potential and calcium channel subunits Ca(V)1.2, Ca(V)1.3 and Ca(V)3.1.
Tanaka H; Namekata I; Ogawa T; Tsuneoka Y; Komikado C; Takahara A; Iida-Tanaka N; Izumi-Nakaseko H; Tsuru H; Adachi-Akahane S
Eur J Pharmacol; 2010 Dec; 649(1-3):263-7. PubMed ID: 20858482
[TBL] [Abstract][Full Text] [Related]
5. Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes.
Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
Life Sci; 2000 Dec; 68(3):345-51. PubMed ID: 11191650
[TBL] [Abstract][Full Text] [Related]
6. Effects of mibefradil, a selective T-type Ca2+ channel antagonist, on sino-atrial node and ventricular myocardia.
Masumiya H; Kase J; Tanaka Y; Tanaka H; Shigenobu K
Res Commun Mol Pathol Pharmacol; 1999; 104(3):321-9. PubMed ID: 10741382
[TBL] [Abstract][Full Text] [Related]
7. Possible requirement of phosphonate moiety for efonidipine effects on the sino-atrial node action potential.
Masumiya H; Matsuda T; Tanaka Y; Tanaka H; Shigenobu K
Life Sci; 2000; 66(16):PL239-44. PubMed ID: 10794505
[TBL] [Abstract][Full Text] [Related]
8. Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms.
Lee TS; Kaku T; Takebayashi S; Uchino T; Miyamoto S; Hadama T; Perez-Reyes E; Ono K
Pharmacology; 2006; 78(1):11-20. PubMed ID: 16899990
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
Higashino R; Sato R; Jin H; Inoue N; Fukuta Y; Kurimoto T; Tamaki H
J Cardiovasc Pharmacol; 1997 May; 29(5):624-30. PubMed ID: 9213205
[TBL] [Abstract][Full Text] [Related]
10. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
Tanaka H; Komikado C; Shimada H; Takeda K; Namekata I; Kawanishi T; Shigenobu K
J Pharmacol Sci; 2004 Dec; 96(4):499-501. PubMed ID: 15599089
[TBL] [Abstract][Full Text] [Related]
11. Species difference in the contribution of T-type calcium current to cardiac pacemaking as revealed by r(-)-efonidipine.
Tanaka H; Komikado C; Namekata I; Nakamura H; Suzuki M; Tsuneoka Y; Shigenobu K; Takahara A
J Pharmacol Sci; 2008 May; 107(1):99-102. PubMed ID: 18460822
[TBL] [Abstract][Full Text] [Related]
12. A selective T-type Ca2+ channel blocker R(-) efonidipine.
Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of T-type and L-type Ca(2+) currents by aranidipine, a novel dihydropyridine Ca(2+) antagonist.
Masumiya H; Tanaka Y; Tanaka H; Shigenobu K
Pharmacology; 2000 Aug; 61(2):57-61. PubMed ID: 10940777
[TBL] [Abstract][Full Text] [Related]
14. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
Noguchi K; Takahashi K; Higuchi S
J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
[TBL] [Abstract][Full Text] [Related]
15. Selective cardiodepressant activity of fluodipine, a fluorenone-1,4-dihydropyridine derivative.
Budriesi R; Aicardi G; Campana G; Spampinato S; Zaza A; Bisi A; Rampa A; Valenti P; Chiarini A
Eur J Pharmacol; 1998 Oct; 359(2-3):161-70. PubMed ID: 9832387
[TBL] [Abstract][Full Text] [Related]
16. Effect of efonidipine, a novel dihydropyridine derivative, on myocardial metabolic changes induced by coronary artery ligation in dogs: comparison with nifedipine.
Yokoyama T; Ichihara K; Abiko Y
Fundam Clin Pharmacol; 1997; 11(3):245-51. PubMed ID: 9243256
[TBL] [Abstract][Full Text] [Related]
17. Effect of cilnidipine on L- and T-type calcium currents in guinea pig ventricle and action potential in rabbit sinoatrial node.
Takeda K; Yamagishi R; Masumiya H; Tanaka H; Shigenobu K
J Pharmacol Sci; 2004 Jul; 95(3):398-401. PubMed ID: 15272218
[TBL] [Abstract][Full Text] [Related]
18. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
[TBL] [Abstract][Full Text] [Related]
20. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
